Search
Cytek Biosciences Inc
CTKBAdd to Watchlist
3.770USD
-0.210-5.28%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
486.87MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Cytek Biosciences Inc is 7.50, ranking 135 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 5.75, with a high of 7.50 and a low of 4.00.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
5.688
Target Price
+50.86%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
94
Total
3
Median
7
Average
Company name
Ratings
Analysts
Cytek Biosciences Inc
CTKB
4
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Cytek Biosciences Inc's expected revenue for the next quarter?
Cytek Biosciences Inc's expected revenue is 48.61M.
What is Cytek Biosciences Inc's price target?
Analysts forecast that Cytek Biosciences Inc's price target is USD 5.75, with the highest forecast at USD 7.50 and the lowest forecast at USD 4.00.
How have Cytek Biosciences IncCTKB's recent earnings per share performed?
The market expectation was USD -0.15, while Cytek Biosciences IncCTKB's earnings per share (EPS) for the previous quarter was USD -0.34. EPS for the next quarter is expected at USD -0.09.
What is the analyst rating for Cytek Biosciences Inc?
Based on the ratings of Cytek Biosciences Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
